ClinicalIntelPulse

Live 402 challenge

Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.

{
  "error": "X-PAYMENT header is required",
  "accepts": [
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2"
      },
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "scheme": "exact",
      "network": "base",
      "mimeType": "application/json",
      "resource": "https://clinicalintelpulse.theaslangroupllc.com/api/clinical/patient-finder",
      "description": "Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.",
      "maxAmountRequired": "100000",
      "maxTimeoutSeconds": 300
    }
  ],
  "x402Version": 1
}

Accepts

The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.

[
  {
    "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
    "extra": {
      "name": "USD Coin",
      "version": "2"
    },
    "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
    "amount": "100000",
    "scheme": "exact",
    "network": "eip155:8453",
    "maxTimeoutSeconds": 300
  },
  {
    "asset": "EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v",
    "extra": {
      "feePayer": "D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"
    },
    "payTo": "985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1",
    "amount": "100000",
    "scheme": "exact",
    "network": "solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp",
    "maxTimeoutSeconds": 300
  }
]

Extensions

{
  "bazaar": {
    "info": {
      "input": {
        "type": "http",
        "method": "GET",
        "queryParams": {
          "lang": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
          "phase": "phase2 | phase3 | any (default: any)",
          "country": "Optional country filter — e.g. \"United States\" | \"United Kingdom\" | \"Germany\" | \"Australia\"",
          "condition": "Disease or diagnosis — e.g. \"Glioblastoma\" | \"Sickle Cell Disease\" | \"Cystic Fibrosis\" | \"Huntington Disease\""
        }
      },
      "output": {
        "type": "json",
        "example": {
          "how_to_apply": [
            "Step 1: Confirm eligibility by reviewing inclusion/exclusion criteria with your doctor",
            "Step 2: Identify a participating site near you via the ClinicalTrials.gov \"Find a Location\" tab",
            "Step 3: Request a referral from your oncologist/neurologist to the trial site",
            "Step 4: Expect a screening visit to confirm you meet all criteria — most trials cover this at no cost",
            "Step 5: Informed consent process — you can withdraw at any time without affecting your regular care"
          ],
          "query_summary": {
            "as_of": "2026-06-07",
            "phase": "any",
            "country": null,
            "condition": "Glioblastoma"
          },
          "patient_resources": [
            "ClinicalTrials.gov (clinicaltrials.gov)",
            "National Brain Tumor Society (braintumor.org)",
            "NCI Cancer Information (cancer.gov/about-cancer/treatment/clinical-trials)"
          ],
          "highlighted_trials": [
            {
              "url": "https://clinicaltrials.gov/study/NCT04175171",
              "nctId": "NCT04175171",
              "phase": "PHASE3",
              "title": "Study of Nivolumab Combined With Radiation Therapy in Newly Diagnosed Glioblastoma",
              "status": "RECRUITING",
              "sponsor": "Bristol-Myers Squibb",
              "countries": [
                "United States",
                "United Kingdom",
                "Germany",
                "France",
                "Spain"
              ],
              "contact_hint": "Contact your neuro-oncologist or visit clinicaltrials.gov/study/NCT04175171 for site contacts",
              "who_can_join": "Adults (18+) newly diagnosed with glioblastoma (IDH-wildtype), able to receive radiation therapy. MGMT status: any.",
              "who_cannot_join": "Prior brain tumor treatment, autoimmune conditions requiring systemic steroids, prior immunotherapy.",
              "plain_language_summary": "Comparing a standard radiation + chemotherapy approach vs. adding nivolumab (a cancer immunotherapy drug) in newly diagnosed glioblastoma. For adults newly diagnosed."
            }
          ],
          "recruiting_trials_count": 89
        }
      }
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema"
    }
  },
  "builder-code": {
    "info": {
      "a": "bc_gxy6qn5p"
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema",
      "properties": {
        "a": {
          "type": "string",
          "pattern": "^[a-z0-9_]{1,32}$",
          "description": "App builder code"
        },
        "s": {
          "type": "array",
          "items": {
            "type": "string",
            "pattern": "^[a-z0-9_]{1,32}$"
          },
          "description": "Service builder codes"
        },
        "w": {
          "type": "string",
          "pattern": "^[a-z0-9_]{1,32}$",
          "description": "Wallet builder code"
        }
      },
      "additionalProperties": false
    }
  }
}

Provenance

Seen in the source catalog

2026-07-01 04:22Z

Last indexed by Roundhouse

2026-07-30 16:00Z

Last enriched (probe, favicon, geo)

2026-09-11 06:45Z

x402 version

2

Max timeout

300s

Liveness probe

HTTP 402